Annals of Oncology

News:

News
Ann Oncol 3: 176-180.
[PDF] [Request Permissions]

Editorials:

M. J. Piccart, D. de Valeriola, and E. Tomiak

Anthracuclines active via the oral route: Luxury or necessity?
Ann Oncol 3: 181-182.
[PDF] [Request Permissions]

Fernando Cabanillas

To CHOP or not to CHOP ... is that the question?
Ann Oncol 3: 183-185.
[PDF] [Request Permissions]

Book reviews:

A. Goldhirsch

Book review
Ann Oncol 3: 186.
[PDF] [Request Permissions]

Ian Magrath

Book review
Ann Oncol 3: 191-192.
[PDF] [Request Permissions]

N. Lüscher

Book review
Ann Oncol 3: 196.
[PDF] [Request Permissions]

Special articles:

C. De Bellefeuille, C. A. Morrison, and I. F. Tannock

The fate of abstracts submitted to a cancer meeting: Factors which influence presentation and subsequent publication
Ann Oncol 3: 187-191.
[Abstract] [PDF] [Request Permissions]

Commentary:

R. A. Joss

Sixth World Conference on lung cancer-Melbourne, November 10th-14th, 1991
Ann Oncol 3: 193-195.
[PDF] [Request Permissions]

Arena:

J. Wils and D. J. Th. Wagener

Combined modality adjuvant treatment of high-risk rectal cancer: A treatment of choice or a choice of treatment?
Ann Oncol 3: 197-199.
[PDF] [Request Permissions]

Original articles:

D. J. Stewart, E. A. Eisenhauer, J. Skillings, K. I. Pritchard, R. Buckman, T. Vandenberg, S. Verma, S. Aitken, and B. Norris

Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study
Ann Oncol 3: 201-204.
[Abstract] [PDF] [Request Permissions]

S. Pavlovsky, M. T. Santarelli, A. Erazo, J. C. Diaz Maqueo, N. Somoza, M. Lluesma Goñalons, G. Cervantes, E. L. Garcia Vela, C. Corrado, H. Magnasco, and G. Milone

Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP
Ann Oncol 3: 205-209.
[Abstract] [PDF] [Request Permissions]

G. Pizzocaro, R. Salvioni, L. Piva, M. Faustini, N. Nicolai, and L. Gianni

Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results
Ann Oncol 3: 211-216.
[Abstract] [PDF] [Request Permissions]

K. Kjorstad, A. Harris, K. Bertelsen, M. Slevin, H. Schultz, K. Hellman, N. Janssens, A. Martin, and R. Canetta

A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report
Ann Oncol 3: 217-222.
[Abstract] [PDF] [Request Permissions]

For the EORTC Head and Neck Cancer Cooperative Group, J. H. Schornagel, J. Verweij, P. H. M. de Mulder, F. Cognetti, J. B. Vermorken, P. Cappelaere, J. P. Armand, J. Wildiers, M. Clavel, A. Kirkpatrick, and J. L. Lefebvre

A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck
Ann Oncol 3: 223-226.
[Abstract] [PDF] [Request Permissions]

J. A. Spinolo, F. Cabanillas, D. O. Dixon, S. M. Khorana, P. McLaughlin, W. S. Velasquez, F. B. Hagemeister, J. R. Redman, and F. Swan, Jr.

Therapy of relapsed or refractory low-grade follicular lymphomas: Factors associated with complete remission, survival and time to treatment failure
Ann Oncol 3: 227-232.
[Abstract] [PDF] [Request Permissions]

G. Tagliabue, S. Filippeschi, H. Hendricks, and M. D'lncalci

Antitumor activity of 1, 4-bis (2'-chloroethyl)-l, 4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis Maleate) in M5076 and its subline resistant to cyclophosphamide M5/CTX
Ann Oncol 3: 233-236.
[Abstract] [PDF] [Request Permissions]

Short reports:

M. D. Magri, S. Foladore, A. Veronesi, C. Serra, M. Nicotra, M. Tommasi, G. Grandi, S. Monfardini, and C. Bianchi

Treatment of malignant mesothelioma with epirubicin and ifosfamide: A phase II cooperative study
Ann Oncol 3: 237-238.
[Abstract] [PDF] [Request Permissions]

A. M. Hendrick, D. Simmons, and B. M. J. Cantwell

Allergic reactions to carboplatin
Ann Oncol 3: 239-240.
[PDF] [Request Permissions]

J. Verweij, A. S. Th. Planting, M. de Boer, M. E. L. van der Burg, and G. Stoter

Frequent administration of Dabis Maleate, a phase I study
Ann Oncol 3: 241-242.
[Abstract] [PDF] [Request Permissions]

J. W. Baars, J. Wagstaff, C. E. Hack, G. J. Wolbink, A. J. M. Eerenberg-Belmer, and H. M. Pinedo

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2)
Ann Oncol 3: 243-244.
[PDF] [Request Permissions]

Letters:

F. Di Costanzo

Best treatment for colorectal cancer and confirmatory trials
Ann Oncol 3: 245.
[PDF] [Request Permissions]

B. M. J. Cantwell, C. Hennessy, A. Sawan, P. J. D. K. Dawes, M. Millward, and T. W. J. Lennard

Primary tumour mutant p53 gene protein and epidermal growth factor receptor expression and doxorubicin plus ifosfamide for recurrent breast cancer
Ann Oncol 3: 246-247.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.